In the present study, the gene expression of key players in EMT—CDH1 and VIM—and the MAPK/ERK pathway—EGFR, ERK1, ERK2, c-Jun, and c-Fos—was assessed in paired healthy and neoplastic tissues of the same pancreatic cancer cohort. The gene discussed is MAPK1; the disease is familial pancreatic carcinoma.